Literature DB >> 19155080

Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats.

Ali Keshavarzian1, Ashkan Farhadi, Christopher B Forsyth, Jayanthi Rangan, Shriram Jakate, Maliha Shaikh, Ali Banan, Jeremy Z Fields.   

Abstract

BACKGROUND/AIMS: Not all alcoholics develop liver disease (ALD). Thus, excessive ethanol consumption is necessary, but not sufficient, to induce alcoholic steatohepatitis (ASH) and ALD. Since endotoxemia is present in patients with ALD, it has been proposed that gut-derived, circulating endotoxin is the necessary co-factor for ASH. But, it is not known whether endotoxemia is the consequence or the trigger for ALD. Accordingly, the aim of the current study was to determine whether endotoxemia occurs prior to development of ASH and whether gut leakiness is the primary cause of the endotoxemia in an animal model of ASH.
METHODS: Time courses for development of gut hyperpermeability, nitric oxide production, oxidative injury to the gut, endotoxemia, and liver injury were assessed in rats during 10 weeks of daily alcohol gavage.
RESULTS: Liver fat and serum transaminase increased after 2 weeks, but evidence of liver cell injury and inflammation (ASH) occurred after 8 weeks. Gut leakiness, intestinal oxidative injury, and endotoxemia occurred in weeks 2-4 and progressed thereafter.
CONCLUSIONS: That alcohol-induced gut leakiness and endotoxemia preceded steatohepatitis indicates they are not the consequence of ALD. Our data support the hypothesis that gut leakiness resulting in endotoxemia is a key co-factor (trigger) for ASH.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19155080      PMCID: PMC2680133          DOI: 10.1016/j.jhep.2008.10.028

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  48 in total

1.  Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease.

Authors:  A Keshavarzian; A Banan; A Farhadi; S Komanduri; E Mutlu; Y Zhang; J Z Fields
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

2.  Effects of chronic ethanol administration on intestinal absorption in man in the absence of nutritional deficiency.

Authors:  J Lindenbaum; C S Lieber
Journal:  Ann N Y Acad Sci       Date:  1975-04-25       Impact factor: 5.691

3.  Intestinal-transit and lactose intolerance in chronic alcoholics.

Authors:  A Keshavarzian; F L Iber; M D Dangleis; R Cornish
Journal:  Am J Clin Nutr       Date:  1986-07       Impact factor: 7.045

Review 4.  Alcoholic hepatitis: its therapy and prognosis.

Authors:  J T Galambos
Journal:  Prog Liver Dis       Date:  1972

5.  Alcoholic liver disease.

Authors:  L Lumeng; D W Crabb
Journal:  Curr Opin Gastroenterol       Date:  2000-05       Impact factor: 3.287

6.  Ethanol-induced barrier dysfunction and its prevention by growth factors in human intestinal monolayers: evidence for oxidative and cytoskeletal mechanisms.

Authors:  A Banan; S Choudhary; Y Zhang; J Z Fields; A Keshavarzian
Journal:  J Pharmacol Exp Ther       Date:  1999-12       Impact factor: 4.030

7.  Oxidant-induced disruption of intestinal epithelial barrier function: role of protein tyrosine phosphorylation.

Authors:  R K Rao; R D Baker; S S Baker; A Gupta; M Holycross
Journal:  Am J Physiol       Date:  1997-10

8.  Nitric oxide and its metabolites mediate ethanol-induced microtubule disruption and intestinal barrier dysfunction.

Authors:  A Banan; J Z Fields; H Decker; Y Zhang; A Keshavarzian
Journal:  J Pharmacol Exp Ther       Date:  2000-09       Impact factor: 4.030

Review 9.  Myeloperoxidase: a target for new drug development?

Authors:  E Malle; P G Furtmüller; W Sattler; C Obinger
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

10.  Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2.

Authors:  A A Nanji; U Khettry; S M Sadrzadeh; T Yamanaka
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

View more
  151 in total

Review 1.  Mechanisms of alcohol-mediated hepatotoxicity in human-immunodeficiency-virus-infected patients.

Authors:  Gyongyi Szabo; Samir Zakhari
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

2.  Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver.

Authors:  Michal Ganz; Timea Csak; Bharath Nath; Gyongyi Szabo
Journal:  World J Gastroenterol       Date:  2011-11-21       Impact factor: 5.742

Review 3.  Regulation of intestinal epithelial permeability by tight junctions.

Authors:  Takuya Suzuki
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

Review 4.  Zinc and liver disease.

Authors:  Mohammad K Mohammad; Mohammad K Mohommad; Zhanxiang Zhou; Matthew Cave; Ashutosh Barve; Craig J McClain
Journal:  Nutr Clin Pract       Date:  2012-02       Impact factor: 3.080

5.  Gut region-dependent alterations of nitrergic myenteric neurons after chronic alcohol consumption.

Authors:  Mária Bagyánszki; Nikolett Bódi
Journal:  World J Gastrointest Pathophysiol       Date:  2015-08-15

6.  Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury.

Authors:  Gail A Cresci; Bryan Glueck; Megan R McMullen; Wei Xin; Daniella Allende; Laura E Nagy
Journal:  J Gastroenterol Hepatol       Date:  2017-09       Impact factor: 4.029

7.  Targeting the gut barrier for the treatment of alcoholic liver disease.

Authors:  Zhanxiang Zhou; Wei Zhong
Journal:  Liver Res       Date:  2017-12

8.  Effects of moderate, voluntary ethanol consumption on the rat and human gut microbiome.

Authors:  Kassi L Kosnicki; Jerrold C Penprase; Patricia Cintora; Pedro J Torres; Greg L Harris; Susan M Brasser; Scott T Kelley
Journal:  Addict Biol       Date:  2018-05-11       Impact factor: 4.280

9.  Ethanol-induced mast cell-mediated inflammation leads to increased susceptibility of intestinal tumorigenesis in the APC Δ468 min mouse model of colon cancer.

Authors:  Andre L Wimberly; Christopher B Forsyth; Mohammad W Khan; Alan Pemberton; Khashayarsha Khazaie; Ali Keshavarzian
Journal:  Alcohol Clin Exp Res       Date:  2013-01       Impact factor: 3.455

Review 10.  Circadian rhythms, alcohol and gut interactions.

Authors:  Christopher B Forsyth; Robin M Voigt; Helen J Burgess; Garth R Swanson; Ali Keshavarzian
Journal:  Alcohol       Date:  2014-11-14       Impact factor: 2.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.